scholarly journals Downregulation of β1 Integrins by Ebola Virus Glycoprotein: Implication for Virus Entry

Virology ◽  
2000 ◽  
Vol 278 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Ayato Takada ◽  
Shinji Watanabe ◽  
Hiroshi Ito ◽  
Katsunori Okazaki ◽  
Hiroshi Kida ◽  
...  
2016 ◽  
Vol 127 ◽  
pp. 20-31 ◽  
Author(s):  
Xu Zhang ◽  
Zhujun Ao ◽  
Alexander Bello ◽  
Xiaozhuo Ran ◽  
Shuiping Liu ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0152527 ◽  
Author(s):  
Jinwoo Lee ◽  
Sonia M. Gregory ◽  
Elizabeth A. Nelson ◽  
Judith M. White ◽  
Lukas K. Tamm

Viruses ◽  
2018 ◽  
Vol 10 (4) ◽  
pp. 152 ◽  
Author(s):  
Qinghua Cui ◽  
Ruikun Du ◽  
Manu Anantpadma ◽  
Adam Schafer ◽  
Lin Hou ◽  
...  

2017 ◽  
Vol 13 (5) ◽  
pp. e1006397 ◽  
Author(s):  
Mathieu Iampietro ◽  
Patrick Younan ◽  
Andrew Nishida ◽  
Mukta Dutta ◽  
Ndongala Michel Lubaki ◽  
...  

Viruses ◽  
2018 ◽  
Vol 10 (12) ◽  
pp. 678 ◽  
Author(s):  
Qinghua Cui ◽  
Han Cheng ◽  
Rui Xiong ◽  
Gang Zhang ◽  
Ruikun Du ◽  
...  

Ebola virus is the causative agent of Ebola virus disease in humans. The lethality of Ebola virus infection is about 50%, supporting the urgent need to develop anti-Ebola drugs. Glycoprotein (GP) is the only surface protein of the Ebola virus, which is functionally critical for the virus to attach and enter the host cells, and is a promising target for anti-Ebola virus drug development. In this study, using the recombinant HIV-1/Ebola pseudovirus platform we previously established, we evaluated a small molecule library containing various quinoline compounds for anti-Ebola virus entry inhibitors. Some of the quinoline compounds specifically inhibited the entry of the Ebola virus. Among them, compound SYL1712 was the most potent Ebola virus entry inhibitor with an IC50 of ~1 μM. The binding of SYL1712 to the vial glycoprotein was computationally modeled and was predicted to interact with specific residues of GP. We used the time of the addition assay to show that compound SYL1712 blocks Ebola GP-mediated entry. Finally, consistent with being an Ebola virus entry inhibitor, compound SYL1712 inhibited infectious Ebola virus replication in tissue culture under biosafety level 4 containment, with an IC50 of 2 μM. In conclusion, we identified several related molecules with a diaryl-quinoline scaffold as potential anti-EBOV entry inhibitors, which can be further optimized for anti-Ebola drug development.


2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
James Foresman ◽  
Bill Lackamp ◽  
Adrian McAfee ◽  
Marie Montague ◽  
Daniel Mungula ◽  
...  

1997 ◽  
Vol 94 (26) ◽  
pp. 14764-14769 ◽  
Author(s):  
A. Takada ◽  
C. Robison ◽  
H. Goto ◽  
A. Sanchez ◽  
K. G. Murti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document